Related Experiment Video
Updated: Jun 19, 2026

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
Published on: July 31, 2021
STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : II. THE INFECTIVITY OF TYPE III PNEUMOCOCCUS FOR RABBITS
1Hospital of The Rockefeller Institute for Medical Research.
Abstract:
THE OBSERVATIONS RECORDED IN THIS PAPER ON THE INFECTIVITY OF TYPE III PNEUMOCOCCI FOR RABBITS MAY BE SUMMARIZED AS FOLLOWS: 1. Of eleven strains of Type III isolated from human sources, ten were found to possess low virulence for rabbits. This was true despite the fact that all the strains tested possessed large capsules and a high degree of virulence for mice. 2. One strain of Type III pneumococcus was rendered highly virulent for rabbits. Since it possessed no other biological property demonstrably different from the other strains, its virulence must reside in some additional property. 3. An initial decrease in the number of circulating organisms following the injection of virulent bacteria is a well known occurrence, and it was observed in rabbits injected with the rabbit virulent strain of Type III. However, the extent of the reduction was in inverse proportion to the degree of virulence of the strain; a fact which makes mechanical explanations of the phenomenon insufficient. 4. The bacteremia produced in rabbits by Type III pneumococci, avirulent for this species, runs a characteristic course. It differs from that produced by non-encapsulated R forms of pneumococci although in both instances survival of the infected animal ensues. This is evidence that the mechanism of resistance against encapsulated and non-encapsulated pneumococci is not identical. 5. Phagocytosis of Type III pneumococci by circulating rabbit leucocytes was not demonstrable by a vital stain technique, whereas under the same conditions the ingestion of non-encapsulated R forms occurred. This is further evidence that the process whereby non-encapsulated pneumococci are disposed of, is insufficient to explain the natural resistance of rabbits to infection with encapsulated Type III pneumococci.
Insights
Most Type III pneumococci strains are not infectious to rabbits, but one strain showed high virulence. Rabbit resistance to encapsulated bacteria differs from non-encapsulated forms, suggesting unique immune mechanisms.
Area of Science:
- Microbiology
- Immunology
- Bacterial Pathogenesis
Background:
- Type III pneumococci are typically virulent in mice but show variable infectivity in rabbits.
- The mechanisms underlying host resistance to encapsulated bacteria are not fully understood.
Purpose of the Study:
- To investigate the infectivity of human-sourced Type III pneumococci strains in rabbits.
- To explore the differences in host response to encapsulated versus non-encapsulated pneumococci.
Main Methods:
- Inoculation of rabbits with various strains of Type III pneumococci.
- Observation of bacterial virulence, bacteremia course, and phagocytosis by leukocytes.
- Comparison of responses to encapsulated and non-encapsulated pneumococci.
Main Results:
- Ten out of eleven Type III pneumococci strains exhibited low virulence in rabbits, despite high virulence in mice.
- One strain was highly virulent for rabbits, suggesting an uncharacterized property.
- Rabbit resistance mechanisms differ for encapsulated (Type III) and non-encapsulated pneumococci, with limited phagocytosis observed for encapsulated forms.
Conclusions:
- Rabbit immunity against Type III pneumococci is not solely dependent on phagocytosis.
- The infectivity of Type III pneumococci in rabbits is strain-dependent and involves mechanisms beyond capsule presence.
- Further research is needed to elucidate the specific factors contributing to rabbit resistance against encapsulated pneumococci.

